Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion -January 30, 2024 at 08:31 am EST
Record Q1 net revenues of $19.5 million, representing an 89% increase compared to the $10.3 million of net revenues generated in Q1 2023 Q1 operating income of $3.4 million, representing an 201%...
Source: marketscreener.com